causal
Eye as Immune-Privileged Target Site
The retina sits in an immune-privileged site where the immune system has limited access to foreign particles, so a viral-vector gene therapy delivered there triggers less immune reaction, making the eye a smart first target for gene therapy.
causalpending
Speaker
JeffEvidence Quote
“when you put a virus or a virus design vector into that space, it is immuno-privileged site. And so therefore, you don't have the same reaction to something that looks foreign.”
Created: 11/11/2026, 6:53:25 PM
Your notes
Loading notes...